home / stock / phge / phge articles

PHGE Articles, Chardan Healthcare Acquisition Corp.

Stock Information
Company Name: Chardan Healthcare Acquisition Corp.
Stock Symbol: PHGE
Market: NYSE
Website: biomx.com
Menu
PHGE PHGE Quote PHGE Short PHGE News PHGE Articles PHGE Message Board
Get PHGE Alerts

News, Short Squeeze, Breakout and More Instantly...
BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024 | Benzinga

GAITHERSBURG, Maryland and NESS ZIONA, Israel, May 15, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a clinical-st...
BiomX to Present at the 2024 RBC Capital Markets Global Healthcare Conference | Benzinga

CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 06, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a clinical-stage co...

BiomX to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on April 3rd, 2024 | Benzinga

CAMBRIDGE, Mass. and NESS ZIONA, Israel, March 27, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a clinical-stage ...

BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing | Benzinga

Acquisition creates leading phage therapy company with an advanced pipeline that includes two Phase 2 assets, BX004 for the treatment of chronic p...
Why BiomX Stock Is Surging Today | Benzinga

BiomX Inc. (AMEX:PHGE) shares are trading higher Wednesday after the company announced it has entered into a definitive merger agreement with Adapt...

BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing | Benzinga

Acquisition will create phage therapy company with an advanced pipeline with two Phase 2 assets, BX004 for the treatment of chronic pulmonary infe...

BiomX to Host Virtual Key Opinion Leader (KOL) Event to Review the Positive Results from Part 2 of Phase 1b/2a Trial of BX004 in Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Infections on December 4, 2023 | Benzinga

CAMBRIDGE, Mass. and NESS ZIONA, Israel, Nov. 30, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a clinical-stage c...
Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Shares of Patterson Companies, Inc. (NASDAQ: PDCO) moved lower during Wednesday’s session after the company reported worse-than-expected seco...

Why Is Bacterial Infection-Focused BiomX Stock Trading Lower Today? | Benzinga

BiomX Inc (NYSE: PHGE) released safety and efficacy results from Part 2 of the Phase 1b/2a trial of BX004 for chronic pulmonary infections cau...

BiomX to Present Data from Ongoing Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis at the 37th Annual North American Cystic Fibrosis Conference | Benzinga

CAMBRIDGE, Mass. and NESS ZIONA, Israel, Oct. 27, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a clinical-stage c...
Next 10